Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 104803
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.104803
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.104803
Table 3 Patients’ final diagnoses and median follow-up times by diagnosis
| Last diagnosis | n (%) | Follow-up (months), median (minimum-maximum) |
| Malignant mesothelioma | 22 (26.8) | 2.5 (1-129) |
| Tuberculosis | 18 (22) | 87.5 (14-142) |
| Ovarian cancer | 17 (20.7) | 25 (3-95) |
| Stomach cancer | 5 (6.1) | 4 (3-12) |
| Colon cancer | 4 (4.9) | 19 (2-56) |
| Cryptogenic liver cirrhosis | 3 (3.7) | 96 (1-134) |
| Lymphoma | 3 (3.7) | 6 (1-69) |
| Pancreatic cancer | 2 (2.4) | 2 (1-3) |
| Gallbladder cancer | 1 (1.2) | 1 (1-1) |
| Cervix cancer | 1 (1.2) | 3 (3-3) |
| Cholangiocarcinoma | 1 (1.2) | 1 (1-1) |
| Neuroendocrine tumor | 1 (1.2) | 10 (10-10) |
| Gastrointestinal stromal tumor | 1 (1.2) | 40 (40-40) |
| Leiomyosarcoma | 1 (1.2) | 2 (2-2) |
| Duodenum adenocarcinoma | 1 (1.2) | 9 (9-9) |
| Churg-Strauss syndrome | 1 (1.2) | 10 (10-10) |
- Citation: Caliskan AR, Erdogan MA, Baskiran A, Ocal IH, Kacmaz H. Evaluation of diagnostic laparoscopy results in Turkish patients with unexplained ascites. World J Gastrointest Surg 2025; 17(5): 104803
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/104803.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.104803